ValyouNewsExploreMeet Val
Financestocks

Abbott Stock (ABT) Clears 100-Day Average — But Is the Downtrend Really Over?

Seeking Alpha · July 16, 2026

Key takeaways

Abbott Laboratories (ABT) just did something its chart hasn't managed in a while — it pushed decisively above its 100-day moving average. For technical traders, that's a meaningful short-term win. But before you get too excited, the bigger picture tells a more cautious story: the stock is still trading below key long-term trendlines that have capped it for months.

What Actually Happened

Shares of Abbott rallied enough to break through the 100-day moving average, a widely watched technical level that traders use to gauge intermediate-term momentum. Crossing above it typically signals that buying pressure is starting to outweigh selling pressure over a multi-month window. It's a bullish signal on its own — but context matters.

Why the Long-Term Chart Still Looks Shaky

Here's the catch: the 100-day move doesn't erase the longer downtrend that's been in place. Abbott's chart still shows lower highs and lower lows over a longer stretch, meaning the stock has been in a defined downtrend for a while. Breaking a shorter-term moving average is a first step, not proof the trend has reversed. Technicians typically want to see the stock also clear longer-term averages (like the 200-day) and hold above prior resistance zones before calling an actual trend change.

Think of it like a football team gaining first downs but still trailing on the scoreboard. Progress, sure — but the game isn't won yet.

What This Means If You Own or Are Watching ABT

For healthcare and dividend-focused investors who've held Abbott through recent volatility, this bounce is encouraging, especially if it's backed by decent volume. But if you're considering a new position based purely on this crossover, it's worth waiting for confirmation: a sustained close above longer-term resistance, or a retest of the 100-day level that holds rather than fails.

Abbott remains a core healthcare and diagnostics name with a long dividend history, so fundamentals-driven investors may care less about short-term chart signals. But for anyone trading around technical levels, this is a "watch and confirm" moment, not a "back up the truck" moment.

The Bottom Line

Abbott stock clearing its 100-day moving average is a genuinely positive technical development, but it hasn't yet undone the longer downtrend that's weighed on shares. Traders should look for follow-through — sustained strength, higher volume, and a break of longer-term resistance — before assuming the tide has fully turned.

Why it matters

If you hold Abbott stock or track healthcare names, this crossover matters for timing entries and exits — but chasing a single technical signal without confirmation can backfire. Understanding the difference between short-term and long-term trend signals helps you avoid getting whipsawed.

#Abbott Laboratories#ABT stock#stock market#technical analysis#healthcare stocks

Source: Seeking Alpha

Want deals on what you love?

Val finds local offers matched to your interests — free to start.

Meet Val

Related

stocks

Nasdaq Slides as AI Valuation Worries Rattle Stocks

Seeking Alpha· 9d ago